Skip to main content

Peer Review reports

From: Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

Original Submission
31 Mar 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
19 May 2015 Editorially accepted
7 Jul 2015 Article published 10.1186/s12886-015-0043-x

You can find further information about peer review here.

Back to article page